Business
Currency:USD
2025/Q1
Stock NameRevenueRatio
Pharma and Consumer Health563M55.03%
Biologics461M45.06%
Inter-segment revenue elimination-1M-0.10%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.82B64.44%
Europe1.36B31.02%
Other356M8.13%
Elimination of revenue attributable to multiple locations-157M-3.58%
